🚀 go-pugleaf

Cancer – Press Review – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (June 11, 2011) – Revue de presse (11 juin 2011)



US trials show continued promise for two new skin cancer treatments
(ipilimumab, vemurafenib)
Two clinical trials presented at the largest annual cancer conference
have raised hopes for new drugs designed to treat malignant melanoma,
the most serious form of skin cancer.
In Cancer Research UK
http://info.cancerresearchuk.org/news/archive/cancernews/2011-06-08-US-trials-show-continued-promise-for-two-new-malignant-melanoma-skin-cancer-treatments-

Older cancer patients more likely to die due to NHS 'age bias'
Study says elderly patients face delays in referrals to specialists
and less chance of radical surgery being proposed.
By Denis Campbell. In The Guardian
http://www.guardian.co.uk/world/2011/jun/09/nhs-older-patients-cancer-bias

Screening for ovarian cancer doesn't reduce tumors or deaths,
researchers say
Screening for ovarian cancer does not reduce the risk of dying from
the disease but does increase the likelihood of unnecessary invasive
procedures.
By Thomas H. Maugh II. In Los Angeles Times
http://articles.latimes.com/2011/jun/05/news/la-heb-ovarian-cancer-screening-06042011

Bankruptcy Risk Nearly Doubles in Year After Cancer Diagnosis
As cancer patients' survival times increase, so do their bankruptcy
rates. That's the finding of a new study by researchers who compared
U.S. bankruptcy court records to cancer registry data from nearly
232,000 adult cancer survivors in western Washington over 14 years.
The investigators reported that, on average, bankruptcy rates
quadrupled within five years of cancer diagnosis.
In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/06/08/bankruptcy-risk-nearly-doubles-in-year-after-cancer-diagnosis

Cancer revolution is possible with more flexible FDA
Last week, at a meeting of the American Society of Clinical Oncology,
ASCO President George Sledge painted a hopeful, but also challenging,
picture about new genomic technologies for fighting cancer. By Paul
Howard. In Washington Examiner
http://washingtonexaminer.com/opinion/op-eds/2011/06/cancer-revolution-possible-more-flexible-fda

Frog-skin drug could treat cancer
Scientists at Queen's University Belfast have won an award for work on
frog and toad skins which could lead to treatments for over 70 major
diseases.
BBC News
http://www.bbc.co.uk/news/uk-northern-ireland-13676752

Is Social Networking Changing the Face of Medicine?
For women rallying against 2009 mammography proposals, Internet was
strategic new tool, expert says.
By Jenifer Goodwin. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/06/08/is-social-networking-changing-the-face-of-medicine

Scientists Identify Surprising Function for Cyclin D1 in Cancer
Scientists suggest that blocking the cell cycle protein cyclin D1 in
tumor cells may provide a new approach to increasing the sensitivity
of a wide range of cancers to radiotherapy.
Genetic Engineering News
http://www.genengnews.com/gen-news-highlights/scientists-identify-surprising-function-for-cyclin-d1-in-cancer/81245282/

Tips for the Grill Master: How to Have a Cancer-Free BBQ
It's summertime, and that means cookouts and BBQs. But that also means
a hike in cancer risk. So the experts at the MD Anderson Cancer Center
in Houston have come up with five simple tips for lowering your risks,
by changing what and how you grill.
By Alice Park. In TIME
http://healthland.time.com/2011/06/10/tips-for-the-grill-master-how-to-have-a-cancer-free-bbq/

Micromet drug helps 75 pct of leukaemia patients
Blinatumomab, an experimental drug from Micromet reduced levels of
cancer cells to undetectable levels in nine out of 12 patients with a
severe form of leukaemia, interim data from a clinical study showed on
Friday.
By Ben Hirschler & Dan Lalor. Reuters
http://www.reuters.com/article/2011/06/10/micromet-cancer-idUSLDE7591GC20110610

L'Afssaps annonce la suspension immédiate du marché des
antidiabétiques Actos et Competact
Les antidiabétiques Actos et Competact, responsables d'une
augmentation significative du cancer de la vessie chez les hommes,
sont "suspendus du marché immédiatement", a annoncé jeudi à le patron
de l'Agence du médicament (Afssaps).
Dans Le Monde
http://www.lemonde.fr/societe/article/2011/06/09/l-afssaps-annonce-la-suspension-immediate-du-marche-des-antidiabetiques-actos-et-competact_1534148_3224.html

Cancer : la médecine marque des points
Plusieurs percées importantes dans la lutte contre le cancer ont été
annoncées lors de la 47e rencontre annuelle de l'American Society of
Clinical Oncology (ASCO), considérée comme l'un des rendez-vous
majeurs en cancérologie.
Radio-Canada
http://www.radio-canada.ca/nouvelles/sante/2011/06/07/001-cancer-congres-bilan.shtml

Ipsen: arrêt d'un développement
Ipsen a annoncé lundi qu'il arrêtait le développement de son
anticancéreux expérimental Irosustat en monothérapie, mais évaluait la
possibilité de le développer en association avec d'autres thérapies
hormonales. Une étude clinique de phase II a montré que le traitement
n'atteindrait pas son critère d'évaluation principal - le pourcentage
de patientes sous traitement plus de six mois sans progression.
Dans Le Figaro
http://www.lefigaro.fr/flash-eco/2011/06/06/97002-20110606FILWWW00566-ipsen-arret-d-un-developpement.php

Les tumeurs et les maladies cardiovasculaires, principales causes de
décès en 2008
Près d'un tiers des 543.139 décès survenus en France en 2008 (29,6%)
ont été causés par des tumeurs, soit plus de 160.000 décès imputables
aux différents types de cancers.
Le Parisien
http://www.leparisien.fr/laparisienne/sante/les-tumeurs-et-les-maladies-cardiovasculaires-principales-causes-de-deces-en-2008-07-06-2011-1485891.php

Un gynécologue s'inquiète de l'évolution du cancer féminin (Sénégal)
Le cancer du sein et le cancer du col de l’utérus sont en train
d’atteindre des proportions de plus en plus élevées chez les femmes
sénégalaises, a estimé Alassane Diouf, gynécologue au Centre
hospitalier national de Pikine, dans la banlieue dakaroise.
Agence de Presse Sénégalaise
http://www.aps.sn/aps.php?page=articles&id_article=81047

Sanofi : le Zaltrap (aflibercept, VEGF Trap), bientôt mis sur le
marché ?
Sanofi prévoit de soumettre des dossiers de demande d'autorisation de
mise sur le marché aux Etats-Unis et en Europe dès le second
semestre.
Par Ludivine Szado. Dans L’Express
http://votreargent.lexpress.fr/bourse/fiches-valeurs/sanofi-aventis-sanofi-le-zaltrap-bientot-mis-sur-le-marche-conseils_158889.html

Cancer de la prostate : le cabozantinib fait fondre les métastases
osseuses
Les premiers résultats du cabozantinib sont sans précédent dans le
cancer de la prostate métastatique.
Le Quotidien du Médecin
http://www.lequotidiendumedecin.fr/information/cancer-de-la-prostate-le-cabozantinib-fait-fondre-les-metastases-osseuses









Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com








Marc Lacroix – Oncowal & Wallogene (06/2011)